Chaoyuan Huang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Evaluation of eradication efficacy and optimization strategies for Helicobacter pylori infection based on real-world data: a multivariable retrospective study.
Journal: Frontiers in medicine
Published: April 29, 2026
Targeting the CD31 immunometabolic axis: Precision strategies for modulating T cell activation, migration, and autophagy.
Journal: Pathology, research and practice
Published: March 20, 2026
Anti-Hepatocellular Carcinoma Effect of Jianpi Huayu Formula: Revealing the Molecular Mechanisms of the CXCR4 - Smad2/3 Pathway in Regulating Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition.
Journal: Integrative cancer therapies
Published: September 13, 2025
Lupus mesenteric vasculitis disguised as urticaria with abdominal pain: a case report with 10 months follow-up observation.
Journal: Frontiers in immunology
Published: August 04, 2025
Epigastric pain of unknown origin, esophageal and gastric involvement: a Henoch-Schönlein Purpura case report.
Journal: Frontiers in medicine
Published: March 07, 2025
The role of SPP1 in MASLD pathogenesis: Therapeutic insights into ursolic acid's mechanisms of action: Correspondence to editorial on "Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease".
Journal: Clinical and molecular hepatology
Published: June 24, 2024
Using Transparent Cap of Endoloop in Emergency Hemostasis as a Novel Rapid Clot Removal Procedure for Acute Upper Gastrointestinal Hemorrhage.
Journal: The American journal of gastroenterology
Published: May 07, 2024
Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 01, 2024
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease.
Journal: Clinical and molecular hepatology
Published: January 18, 2024
Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1.
Journal: Frontiers in pharmacology
Published: November 09, 2023
BBOX1, LACC1, MMP7 and SSTR1 as common predictors in obesity and non-alcoholic fatty liver disease.
Journal: Genes & diseases
Published: January 28, 2023
Last Updated: 09/26/2026